Letter: E

• Elliott, Hon. C. (PC, Newmarket—Aurora)

  • Advancing Oversight and Planning in Ontario’s Health System Act, 2021 (Bill 283), SP1003–SP1010
  • Advertising
    • jurisdiction over, E52
  • Agriculture industry - COVID-19, temporary foreign workers
    • infection control
      • general remarks, E557
  • Alternate-level-of-care (ALC)
    • general remarks, E6, E62
    • reactivation care centres, E509
  • Ambulance services
    • land ambulances
      • government funding, E43
  • Applied behaviour analysis
    • regulation of
      • general remarks, SP1011
  • Assistive Devices Program (ADP)
    • delivery models
      • service contracts, E618
    • funding allocation
      • general remarks, E528
  • Auditor General
    • reports
      • 2017 Annual Report: Ch. 3.10 - Public Health: Chronic Disease Prevention, E49–E50
  • Blood and plasma donation - plasma
    • paid donations, E619
  • Business - COVID-19
    • essential businesses, EM62
    • in-store capacity
      • limits, EM58
  • Cancer
    • screening programs
      • backlog remediation funding, E566
  • Cancer Care Ontario
    • general remarks, E31–E32
  • Consumption and treatment services
    • general remarks, E14
    • government funding, E34
    • review and consultation process, E14
  • Consumption and treatment services - sites
    • geographic distribution, E14
    • licensing criteria, E33
  • COVID-19
    • and immunity, EM73
    • transmission prevention
      • isolation facilities, EM82
  • COVID-19 - data collection
    • general remarks, E499, SP1010
    • information technology systems, E574
    • Ontario Health Data Platform
      • general remarks, E500, E523
    • socio-economic, SP1006–SP1007
  • COVID-19 - essential service workers, compensation
    • pandemic pay
      • eligibility, E500
  • COVID-19 - financial supports
    • provincial
      • general remarks, E580–E581
  • COVID-19 - government response
    • consultations, public health, E540
    • COVID-19 Response Framework: Keeping Ontario Safe and Open (2020)
      • general remarks, E501
    • decision-making structures
      • general remarks, E498
    • general remarks, E498
    • high-transmission communities, E499, E567–568
    • Public Health Ontario
      • role of, E608–E609
    • public health units
      • government funding, E592
      • role of, E591–E592
  • COVID-19 - Health Command Table
    • advisory tables, E498
  • COVID-19 - testing
    • asymptomatic, E498
    • capacity, E498
    • contact tracing
      • case and contact management system, E499
      • COVID Alert app, E499
      • staff, E499, E569
    • government funding, E529, E609
    • locations
      • general remarks, E529
    • physician services, E500
    • rapid testing, E498, E529
    • strategy, E498–E499
    • surveillance testing, E609
    • target populations
      • international travellers, E498
  • COVID-19 - transmission
    • case rates, EM59
    • data modelling, EM67–EM68, EM73–EM74, EM77–EM78, EM82
    • high-transmission communities, EM56, EM77
  • COVID-19 - vaccination
    • high-transmission communities
      • mobile and pop-up clinics, E501, E506
      • selection of, E603
      • vaccination rates, E603
      • vaccine allocations, E501
    • rollout strategy, EM73–EM74, EM82, SP1005
      • general remarks, E552, E603
      • implementation timeline, E512
      • phase I, E500–E501
      • phase II, E501
    • vaccination rates
      • first dose, E501
    • vaccine hesitancy, EM73–EM74
    • vaccine ineligibility, EM74
  • COVID-19 - vaccination, data collection
    • general remarks, E501
  • COVID-19 - vaccination, target populations
    • general remarks, E512
    • health care workers, E532
    • Indigenous communities
      • Operation Remote Immunity, E501, E510, E552
    • students and education workers, E531–E532
  • Crisis services
    • mobile crisis teams, E14
  • Dental care
    • community access points, E23, E64
    • via hospital and primary care, E16, E64
  • Doctors
    • and COVID-19
      • physician services
        • funding, E500
      • virtual care, E500
  • Education - COVID-19, in-school learning
    • testing, E531–E532
  • Emergency orders review, EM56, EM58–EM59, EM61–EM64, EM66
  • Government expenditures
    • budget allocation
      • health and long-term care, E5
  • Health and Supportive Care Providers Oversight Authority
    • regulatory framework
      • general remarks, SP1004–SP1005
  • Health care
    • equity
      • northern Ontario, E516
  • Health care - administration
    • supply chain management, E8, E20, E28
  • Health care facilities
    • nurse practitioner-led clinics
      • general remarks, E589
  • Health care funding
    • Northern Health Travel Grant
      • calculation formula, E516
  • Health care - primary care
    • service capacity
      • rural and northern Ontario, E606
  • Health care services - delivery
    • coordination of care, E6, E18, E41, E65
  • Health care services - virtual delivery
    • general remarks, E516, E534
    • northern Ontario, E516
    • post-surgical care, E518
  • Health care system
    • general remarks, E505
    • patient navigation of, E5–E6
  • Health care system - digital reforms, E6, E12
    • Digital First for Health Strategy
      • general remarks, E534
    • Digital Health Playbook, E65–E66
    • funding allocation
      • platform development and updating, E46, E69
    • general remarks, E46, E65
  • Health care system - reform
    • administrative centralization, E619
      • general remarks, E7, E506
    • consultation process, E19
    • cost, E12, E69
    • general remarks, E6–E7, E16–E17, E40, E505, E619
    • projected cost savings
      • annual targets, E63
      • calculation of, E9
  • Health care workers - COVID-19
    • compensation
      • pandemic pay, E500
    • general remarks, E614
    • recruitment and retention, E500
  • Health professionals - regulation
    • scopes of practice
      • expansion of, E16
      • revision of, E612
  • Home and community care
    • general remarks, E15–E16, E41, E507, E533
    • and Ontario Health teams, E507–E508
  • Home and community care - administration
    • care coordination
      • care coordinators, E65
      • general remarks, E533
      • Home and Community Care Support Services, E507
  • Home and community care - COVID-19
    • government funding, E507
  • Home and community care - funding
    • general remarks, E15, E41, E562
  • Home and community care - reform
    • general remarks, E564
  • Home and community care - service delivery
    • post-surgical
      • virtual delivery, E518
  • Home and community care - staff
    • compensation
      • personal support workers, E539
    • general remarks, SP1004
    • recruitment and retention
      • personal support workers, E539
  • Hospitals - capacity and overcrowding
    • bed development, E623
    • beds, new, E15, E59, E517
    • contributing factors, E517–E518
    • general remarks, E5
    • government strategy, E59
    • patient flow, E62
  • Hospitals - construction
    • general remarks, E509
    • reactivation care centres, E509
  • Hospitals - COVID-19
    • capacity
      • new beds, E499
    • general remarks, E518
    • government funding, E499–E500
    • ICU beds
      • geographic distribution, E517
    • medical procedures
      • backlog, E522, E597
      • backlog funding, E566
      • essential surgeries and procedures, E522, E597
    • revenue loss, E499–E500
    • virtual care delivery, E500
  • Hospitals - funding
    • allocation
      • cancer services, E566
    • base funding, E15
    • capital projects, E15, E59, E509, E623
    • Health Infrastructure Renewal Fund, E509
    • small- and medium-sized
      • stabilization funding, E499
    • surge funding, E15
  • Hospitals - services
    • emergency and acute care
      • dedicated offload nurses program, E509
      • wait times, E5
    • transition out of care
      • cross-agency communication, E5
      • Southlake@Home program, E6, E62
  • Indigenous communities - health
    • jurisdiction regarding, E510
    • reform, E511
    • reform consultation, E510–E511
  • Long-term care - administration
    • licensing applications
      • temporary emergency licences, E15
  • Long-term care - funding
    • government funding, E34
  • Long-term-care beds
    • new
      • development timeline, E14
      • general remarks, E34, E39
      • vs. spaces, E40
    • redevelopment
      • general remarks, E14, E34, E39
    • sector capacity, E14, E34
  • Long-term-care facilities - COVID-19
    • and Ontario Health teams, E506
  • Long-term-care facilities - new, E14–E15
  • Mental health and addictions
    • general remarks, E13
    • sector consultations, E47
  • Mental Health and Addictions Centre of Excellence
    • cost of development, E32
    • and COVID-19
      • advisory role, E507
    • general remarks, E608
    • mandate and role, E32–E33, E508
  • Mental health and addictions - COVID-19
    • general remarks, E545
    • government funding, E508, E545
  • Mental health and addictions services
    • access
      • general remarks, E13, E47
    • community programs
      • structured psychotherapy pilot program, E509
    • during COVID-19
      • service delivery, E508, E545
    • government strategy, E13–E14
    • wait times, E13
  • Mental health and addictions services funding, E13, E27
    • allocation, E13–E14, E31
    • disbursement, E27, E31
    • general remarks, E13, E27, E508
    • Indigenous communities
      • general remarks, E510
  • Mental health and addictions services funding - children and youth, E31
    • school vs. community allocation, E31
  • Mental health and addictions services - Indigenous communities
    • general remarks, E510
  • Mental health and addictions services - Roadmap to Wellness
    • consultation, E508
    • core services framework
      • development of, E508–E509
    • general remarks, E508, E545
  • Mental health and addictions services - service delivery
    • general remarks, E47
  • Midwives
    • education and training
      • bilingual education, E503
      • Laurentian program closure, E503
  • Ministry of Health
    • estimates (2021-2022), E497–E501, E503, E505–E513, E515–E518, E522–E523, E528–E529, E531–E534, E539–E540, E545, E550–E552, E554, E556–E557, E561–E562, E564–E569, E571, E573–E574, E580–E581, E584, E586, E589, E591–E592, E597, E601–E603, E606–E609, E612, E614, E618–E619, E622–E623
    • information technology
      • and COVID-19, E574
  • Ministry of Health and Long-Term Care
    • estimates (2019-2020), E5–E20, E22–E23, E25, E27–E28, E31–E34, E39–E41, E43, E45–E47, E49–E50, E52, E59, E62–E66, E68–E69, E71
  • Nurses - nurse practitioners
    • scope of practice
      • diagnostic imaging, ordering of, E602
  • OHIP+: Children and Youth Pharmacare Program
    • eligibility, E10
    • second payer model, E10
  • Ontario Drug Benefit Program
    • formularies
      • new drug coverage, E71
  • Ontario Health
    • agencies transferred under, E7, E506–E507
    • and COVID-19
      • general remarks, E507
    • general remarks, E619
    • implementation process
      • timeline, E8, E17
    • role and responsibilities, E7–E8
  • Ontario Health - administration
    • performance measurement
      • reporting on, E17
  • Ontario Health - governance
    • board of directors
      • membership, E8
  • Ontario Health teams
    • care coordinators, E65
    • caseload, E19
    • and COVID-19
      • support services, E506
    • general remarks, E6–E7, E20, E505–E506, E586, SP1006
    • implementation process
      • applications, E7, E41
      • general remarks, E506
      • timeline, E7
    • membership
      • doctors, E7
    • number of, E19, E506, E586
    • patient experience, E19
    • performance measurement, E7
    • selection criteria
      • population size, E573
    • services
      • division of providers, E45
      • primary care, E606
  • Ontario Health teams - administration and governance
    • care coordination, E506
    • funding allocation
      • across services, E45, E65
    • governance structure, E65
  • Opioid addiction
    • cost to health care system, E34
  • Opioids
    • manufacturer liability lawsuits
      • general remarks, E34
  • Palliative care
    • service capacity, E41
  • Paramedic services
    • community paramedicine
      • government funding, E562
    • government funding
      • COVID-19 support, E500
  • People's Health Care Act, 2019 (Bill 74)
    • proclamation of, E17
  • Personal health information
    • patient access, E68
  • Personal protective equipment
    • procurement
      • quantities, E581
    • production
      • in Ontario, E581
    • supply, E581
  • Personal support workers (PSWs)
    • role of, SP1004
  • Personal support workers (PSWs) - compensation
    • wage enhancement
      • general remarks, SP1008, SP1010
  • Personal support workers (PSWs) - education and training
    • general remarks, SP1008
  • Personal support workers (PSWs) - recruitment and retention
    • general remarks, E539
    • government funding, SP1008
  • Physician assistants
    • regulation of
      • general remarks, SP1004–SP1005, SP1011
  • Prescription drugs
    • coverage through Trillium Drug Program, E11
  • Public health - funding
    • provincial-municipal cost-sharing, E8, E43
  • Public Health Ontario (PHO)
    • and COVID-19, E608–E609
    • mandate, E609
  • Public health - programs
    • dental care
      • for senior citizens, E12, E16, E23, E50, E64
    • smoking cessation
      • administrative agency, change in, E561
  • Public health units
    • coordination between, E50
    • and COVID-19, E591–E592
    • governance, E8–E9
    • restructuring
      • amalgamation, E8–E9, E12, E50, E515–E516
      • consultation process, E515, E592
  • Smoke-Free Ontario Act, 2017, S.O. 2017, c. 26, Sched. 3
    • general remarks, E25
  • Supply Ontario
    • creation of, E581
  • Surgical procedures
    • backlog
      • funding allocation, E522
    • geographic transfers, E522
  • Task Force on Environmental Health
    • annual report
      • release timeline, E618
  • Trillium Drug Program
    • as backstop for coverage gaps, E11
  • Vaping
    • pulmonary illness due to
      • reporting requirements, E52
  • Vaping and youth
    • prevalence, E52
  • Vaping products
    • e-juice
      • nicotine content, E52
    • marketing and display
      • restrictions, E52